Table 1 Baseline demographic and clinical characteristics of study participants with antenatal corticosteroid treatment
From: Association between antenatal corticosteroid treatment and severe adverse events in pregnant women
Characteristic | N = 52,119 |
|---|---|
Age, mean (SD), year | 31.91 (5.24) |
Gestational weeks at delivery, mean (SD), week | 34.93 (3.33) |
Parity | |
1 | 21,322 (40.91) |
2 | 24,489 (46.99) |
3 | 5309 (10.19) |
≥ 4 | 999 (1.91) |
Delivery mode, n (%) | |
Vaginal | 26,110 (50.10) |
Cesarean | 26,009 (49.90) |
Preterm delivery, n (%) | |
No | 19,728 (37.85) |
Yes | 32,391 (62.15) |
Premature rupture of membranes, n (%) | |
No | 35,199 (67.54) |
Yes | 16,920 (32.46) |
Gestational diabetes, n (%) | |
No | 40,784 (78.25) |
Yes | 11,335 (21.75) |
Gestational hypertension, n (%) | |
No | 44,411 (85.21) |
Yes | 7708 (14.79) |